Experimental Pneumocystis carinii pneumonia in simian immunodeficiency virus-infected rhesus macaques

Journal of Infectious Diseases

Volumn 187, Issue 4, 2003, Pages 576-588

  Board, Kathryn F ^a   Patil, Sangita ^a   Lebedeva, Irina ^a   Capuano III, Saverio ^a   Trichel, Anita M ^a   Murphey Corb, Michael ^a   Rajakumar, Premeela A ^a   Flynn, JoAnne L ^a   Haidaris, Constantine G ^b   Norris, Karen A ^a  

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF ROCHESTER SCHOOL OF MEDICINE AND DENTISTRY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD3 ANTIGEN; CD8 ANTIGEN;

AIDS RELATED COMPLEX; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; COLONY FORMATION; DISEASE COURSE; FEMALE; FLOW CYTOMETRY; INOCULATION; LUNG LAVAGE; LYMPHOCYTE COUNT; MALE; NEUTROPHIL CHEMOTAXIS; NONHUMAN; NUCLEOTIDE SEQUENCE; PNEUMOCYSTIS PNEUMONIA; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RHESUS MONKEY; SIMIAN IMMUNODEFICIENCY VIRUS; SYMPTOMATOLOGY; T LYMPHOCYTE;

AIDS-RELATED OPPORTUNISTIC INFECTIONS; ANIMALS; ANTIGENS, CD3; BRONCHOALVEOLAR LAVAGE FLUID; CD8-POSITIVE T-LYMPHOCYTES; DISEASE MODELS, ANIMAL; DNA, FUNGAL; FEMALE; LUNG; MACACA MULATTA; MALE; NEUTROPHIL INFILTRATION; PNEUMOCYSTIS; PNEUMONIA, PNEUMOCYSTIS; POLYMERASE CHAIN REACTION; SIMIAN ACQUIRED IMMUNODEFICIENCY SYNDROME; SIMIAN IMMUNODEFICIENCY VIRUS; TIME FACTORS;

EID: 0037442809     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1086/373997     Document Type: Article

References (53)

1. Masur H, Michelis M, Greene J, et al. An outbreak of community-acquired Pneumocystis carinii pneumonia: initial manifestation of cellular immune dysfunction. N Engl J Med 1981; 305:1431-8.
2. Gottleib M, Schroff R, Shanker H, et al. Pneumocystis carinii pneumonia and mucosal candidiasis in previously healthy homosexual men: evidence of a new acquired cellular immunodeficiency. N Engl J Med 1981; 305:1425-31.
3. Hanano R, Kaufmann SH. Pneumocystis carinii and the immune response in disease. Trends Microbiol 1998; 6:71-5.
4. Gigliotti F. Host species-specific antigenic variation of a mannosylated surface glycoprotein of Pneumocystis carinii. J Infect Dis 1992; 165:329-36.
5. Gigliotti F, Haidaris PJ, Haidaris CG, Wright TW, Meid VD. Further evidence of host species specific variation in antigens of Pneumocystis carinii using the polymerase chain reaction. J Infect Dis 1993; 168:191-4.
6. Wakefield AE. Genetic heterogeneity in Pneumocystis carinii: an introduction. FEMS Immunol Med Microbiol 1998; 22:5-13.
7. Aliouat EM, Mazars E, Dei-Cas E, Delcourt P, Billaut P, Camus D. Pneumocystis cross infection experiments using SCID mice and nude rats as recipient host, showed strong host-species specificity. J Eukaryot Microbiol 1994; 41:71S.
8. Furuta T, Fujita M, Mukai R, et al. Severe pulmonary pneumocystosis in simian acquired immunodeficiency syndrome induced by simian immunodeficiency virus: its characterization by the polymerase-chain-reaction method and failure of experimental transmission to immunodeficient animals. Parasitol Res 1993; 79:624-8.
9. Gigliotti F, Harmsen AG, Haidaris CG, Haidaris PJ. Pneumocystis carinii is not universally transmissible between mammalian species. Infect Immun 1993; 61:2886-90.
10. Stringer JR. Pneumocystis carinii: what is it, exactly? Clin Microbiol Rev 1996; 9:489-98.
11. Baskin GB, Murphey-Corb M, Watson EA, Martin LN. Necropsy findings in rhesus monkeys experimentally infected with cultured simian immunodefidency virus (SIV) delta. Vet Pathol 1988; 25:456-67.
12. Chalifoux LV, Ringler DJ, King NW, et al. Lymphadenopathy in macaques experimentally infected with the simian immunodeficiency virus. Am J Pathol 1987; 128:104-10.
13. Johnson RP. Macaque models for AIDS vaccine development. Curr Opin Immunol 1996; 8:554-60.
14. Hulskotte EG, Geretti AM, Osterhaus A. Towards an HIV-1 vaccine: lessons from studies in macaque models. Vaccine 1998; 16:904-15.
15. Croix DA, Board K, Capuano S, et al. Alterations in the T lymphocyte profiles in bronchoalveolar lavage fluid in SIV and Pneumocystis carinii co-infected rhesus macaques. AIDS Res Hum Retroviruses 2002; 18:391-401.
16. Fleury J, Escudier E, Pocholle MJ, Carre C, Bernaudin JC. Cell population obtained by bronchoalveolar lavage in Pneumocystis carinii pneumonitis. Acta Cytol 1985; 29:721-6.
17. Rankin JA, Walzer PD, Dwyer JM, Schrader CE, Enriquez RE, Merrill WW. Immunologic alteration in bronchoalveolar lavage fluid in the acquired immunodeficiency syndrome (AIDS). Am Rev Respir Dis 1983; 128:189-94.
18. Sadaghdar H, Huang Z, Eden E. Correlation of bronchoalveolar lavage findings to severity of Pneumocystis carinii pneumonia in AIDS: evidence for the development of high-permeability pulmonary edema. Chest 1992; 102:63-9.
19. Wright TW, Gigliotti F, Finkelstein JN, McBride JT, An CL, Harmsen AG. Immune-mediated inflammation directly impairs pulmonary function, contributing to the pathogenesis of Pneumocystis carinii pneumonia. J Clin Invest 1999; 104:1307-17.
20. Amedee AM, Lacour N, Gierman JL, et al. Genotype selection of simian immunodeficiency virus (SIV) in macaque infants infected transplacentally. J Virol 1995; 69:7982-90.
21. Amedee AM, Lacour N, Martin LN, et al. Analysis of infant macaques infected transplacentally and orally. J Med Primatol 1996; 25:225-35.
22. Grocott RG. A stain for fungi in tissue sections and smears using Gomori's methenamine silver nitrate technique. Am J Clin Pathol 1955; 25:975-9.
23. Wakefield AE, Pixley FJ, Banerji S, et al. Detection of Pneumocystis carinii with DNA amplification. Lancet 1990; 336:451-3.
24. Savoia D, Millesimo M, Cassetta I, Forno B, Caramello P. Detection of Pneumocystis carinii by DNA amplification in human immunodeficiency virus-positive patients. Diagn Microbiol Infect Dis 1997; 29:61-5.
25. Fuller D, Rajakumar P, Wilson L, et al. Induction of mucosal protection against primary, heterologous simian immunodeficiency virus by a DNA vaccine. J Virol 2002; 76:3309-17.
26. Croix DA, Capuano S, Simpson L, et al. Effect of mycobacterial infection on virus loads and disease progression in simian immunodeficiency virus-infected rhesus monkeys. AIDS Res Hum Retroviruses 2000; 16:1895-908.
27. Tsai C, Follis K, Sabo A, et al. Prevention of SIV infection in macaques by (R)-9-(2-phosphonylmethoxypropyl)adenine. Science 1995; 270:1197-9.
28. Mason G, Hashimoto C, Dickman P, Foutty L, Cobb C. Prognostic implications of bronchoalveolar lavage neutrophilia in patients with Pneumocystis carinii pneumonia and AIDS. Am Rev Respir Dis 1989; 139:1336-42.
29. Smith RL, el-Sadr WM, Lewis ML. Correlation of bronchoalveolar lavage cell populations with clinical severity of Pneumocystis carinii pneumonia. Chest 1988; 93:60-4.
30. Cushion MT. Genetic heterogeneity of rat-derived Pneumocystis. FEMS Immunol Med Microbiol 1998; 22:51-8.
31. Palmer RJ, Cushion MT, Wakefield AE. Discrimination of rat-derived Pneumocystis carinii f. sp. carinii and Pneumocystis carinii f. sp. ratti using the polymerase chain reaction. Mol Cell Probes 1999; 13:147-55.
32. Lee CH, Bauer NL, Shaw MM, et al. Proliferation of rat Pneumocystis carinii on cells sheeted on microcarrier beads in spinner flasks. J Clin Microbiol 1993; 31:1659-62.
33. Wakefield AE, Pixley FJ, Banerji S, et al. Amplification of mitochondrial ribosomal RNA sequences from Pneumocystis carinii DNA of rat and human origin. Mol Biochem Parasitol 1990; 43:69-76.
34. Wakefield AE, Fritscher CC, Malin AS, Gwanzura L, Hughes WT, Miller RF. Genetic diversity in human-derived Pneumocystis carinii isolates from four geographical locations shown by analysis of mitochondrial rRNA gene sequences. J Clin Microbiol 1994; 32:2959-61.
35. Lu JJ, Bartlett MS, Shaw MM, Smith JW, Lee CH. Typing of Pneumocystis carinii strains that infect humans based on nucleotide sequence variations of internal transcribed spacers of rRNA genes. J Eukaryot Microbiol 1994; 41:102S.
36. Agostini C, Adami F, Poulter LW, et al. Role of bronchoalveolar lavage in predicting survival of patients with human immunodeficiency virus infection. Am J Respir Crit Care Med 1997; 156:1501-7.
37. Siminski J, Kidd P, Phillips GD, Collins C, Raghu G. Reversed helper/suppressor T-lymphocyte ratio in bronchoalveolar lavage fluid from patients with breast cancer and Pneumocystis carinii pneumonia. Am Rev Respir Dis 1991; 143:437-40.
38. Venet A, Dennewald G, Sandron D, Stern M, Jaubert F, Leibowitch J. Bronchoalveolar lavage in acquired immunodeficiency syndrome. Lancet 1983; 2:53.
39. Wallace JM, Barbers RG, Oishi JS, Prince H. Cellular and T-lymphocyte subpopulation profiles in bronchoalveolar lavage fluid from patients with acquired immunodeficiency syndrome and pneumonitis. Am Rev Respir Dis 1984; 130:786-90.
40. Young RK, Rankin JA, Naegel GP, Paul ES, Reynolds HY. Bronchoalveolar lavage cells and protein in patients with the acquired immunodeficiency syndrome. Ann Intern Med 1985; 103:522-33.
41. Beck JM, Warnock ML, Curtis JL, et al. Inflammatory responses to Pneumocystis carinii in mice selectively depleted of helper T lymphocytes. Am J Respir Cell Mol Biol 1991; 5:186-97.
42. + cells in resistance to Pneumocystis carinii pneumonia in mice. J Exp Med 1990; 172:937-45.
43. Limper AH, Offord KP, Smith TF, Martin WJ 2nd. Pneumocystis carinii pneumonia: differences in lung parasite number and inflammation in patients with and without AIDS. Am Rev Respir Dis 1989; 140:1204-9.
44. Smith R, Berkowitz K, Aranda C. Bronchoalveolar lavage neutrophilia seen in Pneumocystis pneumonia presenting with pneumothorax. Chest 1991; 100:865-7.
45. Harmsen AG, Chen W, Gigliotti F. Active immunity to Pneumocystis carinii reinfection in T-cell-depleted mice. Infect Immun 1995; 63:2391-5.
46. Levy JA. The value of primate models for studying human immunodeficiency virus pathogenesis. J Med Primatol 1996; 25:163-74.
47. Yanai T, Chalifoux LV, Mansfield K, Lackner A, Simon M. Pulmonary cryptosporidiosis in simian immunodeficiency virus-infected rhesus macaques. Vet Pathol 2000; 37:472-5.
48. Kaup F, Matz-Rensing K, Kuhn E, Hunerbein P, Stahl-Henning C, Hunsmann G. Gastrointestinal pathology in rhesus monkeys with experimental SIV infection. Pathobiology 1998; 66:159-64.
49. Kuhn E, Stolte N, Matz-Rensing K, et al. Immunohistochemical studies of productive rhesus cytomegalovirus infection in rhesus monkeys (Macaca mulatta). Vet Pathol 1999; 36:51-6.
50. Baroncelli S, Barry P, Capitanio J, Lerche N, Otsyula M, Mendoza S. Cytomegalovirus and simian immunodeficiency virus coinfection: longitudinal study of antibody response and disease progression. J Acquir Immune Defic Syndr Hum Retrovirol 1997; 15:5-15.
51. Baskerville A, Dowsett AB, Cook RW, Dennis MJ, Cranage MP, Greenway PJ. Pneumocystis carinii pneumonia in simian immunodeficiency virus infection: immunohistological and scanning and transmission electron microscopical studies. J Pathol 1991; 164:175-84.
52. Demanche C, Berthelemy M, Petit T, et al. Phylogeny of Pneumocystis carinii from 18 primate species confirms host specificity and suggests coevolution. J Clin Microbiol 2001; 39:2126-33.
53. Wright TW, Gigliotti F, Haidaris CG, Simpson-Haidaris PJ. Cloning and characterization of a conserved region of human and rhesus macaque Pneumocystis gpA. Gene 1995; 167:185-9.